Catalyst Wire Dossier Catalyst Wire Dossier

Anthelios Fluide 100 KA+ UVMune 400

· Cosmetique Active International
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anthelios Fluide 100 KA+ UVMune 400, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses [NA]

See pricing